- Supported exchanges /
- ST /
- KLAR.ST
Klaria Pharma Holding AB (KLAR ST) stock market data APIs
Klaria Pharma Holding AB (publ.) operates as a pharmaceutical company. It develops Sumatriptan for the treatment of migraine. The company also develops Epinephrine/Adrenaline, which is in Phase I clinical trial for the treatment of acute allergic reaction. In addition, its pre-clinical product is Sirolimus for prevention of organ transplant rejection. Further, the company focuses on the commercialization of cannabis/cannabinoids. Klaria Pharma Holding AB (publ.) was incorporated in 2014 and is headquatered in Uppsala, Sweden.
Klaria Pharma Holding AB Financial Data Overview
| 0.167 | |
| 0.41 | |
| - | |
| 0.297 | |
| 0.519 | |
| 0.14-1.145 | |
| 62 155 K | |
| 130 M | |
| -6 528 000 | |
| -0.1051 | |
| 0.443 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Klaria Pharma Holding AB Fundamental Data is available in our Financial Data APIs
- Net Revenue -6 528 000
- EBITDA -10 756 000
- Earnings Per Share -0.16
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Klaria Pharma Holding AB Earnings via APIs
- Latest Release 2024-08-26
- EPS/Forecast NaN
Get Klaria Pharma Holding AB End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
